In part six of a series from the OSN Technology and Equipment Workshop featured at Hawaiian Eye 2010, Jack T. Holladay, MD, MSEE, FACS, presented a new contrast sensitivity testing device that offers ...

CALGARY, ALBERTA - January 13, 2025 (NEWMEDIAWIRE) - Voyageur Pharmaceuticals Ltd. (TSX.V:VM) (OTC Pink:VYYRF) ("Voyageur" or the "Company") is pleased to announce that it has begun human testing on ...

Please provide your email address to receive an email when new articles are posted on . A new contrast sensitivity test demonstrated high reliability in identifying patients with glaucoma, according ...

VIENNA, Austria — Compared with subcutaneous interferon β-1a (IFNB-1a; Rebif/EMD Serono/Pfizer), treatment with alemtuzumab (Lemtrada, Genzyme/Sanofi) improved visual outcomes in treatment-naive ...

Calgary, Alberta, Canada – TheNewswire - January 13, 2025 - Voyageur Pharmaceuticals Ltd. (TSX.V:VM) (OTC Pink:VYYRF) ("Voyageur" or the "Company") is pleased to announce that it has begun human ...